TNF and severe combined immunodeficiency: At-risk patients include those with severe acquired immunodeficiency syndrome (AIDS), severe combined immunodeficiency disease (SCID), and blood cell dyscrasias like leukemias and lymphomas, diabetics, and individuals receiving inflammatory modulators like corticosteroids, TNF-α inhibitors, and immunosuppressants [8,9,10,11,12].